Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-26-017242
Filing Date
2026-03-12
Accepted
2026-03-12 16:11:54
Documents
103
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K allo-20251231.htm   iXBRL 10-K 2097748
2 EX-23.1 allo-20251231xex231.htm EX-23.1 3823
3 EX-31.1 allo-20251231xex311.htm EX-31.1 10647
4 EX-31.2 allo-20251231xex312.htm EX-31.2 10171
5 EX-32.1 allo-20251231xex321.htm EX-32.1 5781
6 EX-32.2 allo-20251231xex322.htm EX-32.2 5569
12 allo-20251231_g1.jpg GRAPHIC 96525
13 allo-20251231_g2.jpg GRAPHIC 85980
14 allo-20251231_g3.jpg GRAPHIC 120872
15 allo-20251231_g4.jpg GRAPHIC 25109
16 allo-20251231_g5.jpg GRAPHIC 28959
17 allo-20251231_g6.jpg GRAPHIC 28417
18 allo-20251231_g7.jpg GRAPHIC 131709
  Complete submission text file 0001628280-26-017242.txt   11905253

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20251231.xsd EX-101.SCH 87249
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20251231_cal.xml EX-101.CAL 94229
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20251231_def.xml EX-101.DEF 463470
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20251231_lab.xml EX-101.LAB 965579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20251231_pre.xml EX-101.PRE 714698
106 EXTRACTED XBRL INSTANCE DOCUMENT allo-20251231_htm.xml XML 1241680
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38693 | Film No.: 26747825
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)